Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
07:45am, Tuesday, 06'th Jun 2023
Fulgent Genetics is seeing its base of revenue shift to non-COVID testing products. It's also starting to develop medicines in house after a recent acquisition.
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
08:20am, Tuesday, 23'rd May 2023
Certain biotechs that hit it big early during the pandemic are now undervalued. BioNTech is preparing for a rapid pace of new drug launches.
What To Expect From Fulgent Genetics In 2023
01:47am, Sunday, 14'th May 2023
We initiate our coverage of Fulgent Genetics with an "outperform" rating and a $42 target price for the next 12 months. The company is continuing its Phase 1 clinical trial evaluating the efficacy of
Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?
11:26am, Monday, 08'th May 2023
Here is how Fulgent Genetics, Inc. (FLGT) and Masimo (MASI) have performed compared to their sector so far this year.
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates
09:54am, Friday, 05'th May 2023
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to earnings of $4.93 per share a year ago.
7 Stocks to Buy to Bag Big-Time Returns in Q2
02:01pm, Sunday, 16'th Apr 2023
If you're the type that runs toward danger, these stocks to buy may be right for you. To facilitate mobility, the enterprises on this list feature a market capitalization between $500 million to $2 bi
Are Medical Stocks Lagging Fulgent Genetics (FLGT) This Year?
11:24am, Wednesday, 12'th Apr 2023
Here is how Fulgent Genetics, Inc. (FLGT) and Harrow Health (HROW) have performed compared to their sector so far this year.
Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year?
11:25am, Thursday, 09'th Mar 2023
Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Fulgent Genetics, Inc. (FLGT) Q4 2022 Earnings Call Transcript
11:16pm, Tuesday, 28'th Feb 2023
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Melanie Solomon - Investor Relations Ming Hsieh - Chief Executive Officer Brand
Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates
09:50pm, Tuesday, 28'th Feb 2023
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.29% and 13.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Fulgent Genetics: Attractive Valuation, But I Prefer To Hold For Now
11:37am, Monday, 20'th Feb 2023
Ultra strong balance sheet that has a liquid asset balance almost equivalent to its current market capitalization. Profitable core laboratory testing business even without the temporary COVID-19 windf
Fulgent Genetics: Surviving The Covid Cliff
06:20am, Sunday, 19'th Feb 2023
Today, we revisit Fulgent Genetics. The company continues to manage through a huge drop off in Covid testing revenues as the pandemic ebbs. However, 'core' testing sales are seeing impressive growth
My Top 7 Strong Conviction Buys for 2023
08:11am, Thursday, 15'th Dec 2022
Investors who avoided losing money this year are positioned to consider stocks that are strong conviction buys. An investment idea earns that level of faith when management demonstrates a consistent h
At EV/Sales Below 1x, Fulgent Is Undervalued
11:30am, Thursday, 08'th Dec 2022
As the COVID testing frenzy winds down, FLGT is faced with a pleasant problem: what to do with the money it has amassed during the pandemic. Its $880 million dry powder represents a major war chest th
The 7 Best Mid-Cap Stocks to Buy Right Now
12:55pm, Thursday, 01'st Dec 2022
While the large-capitalization firms attract massive institutional support and the small enterprises grab retail eyeballs, the center lane investments – even those labeled the best mid-cap stocks to
